Predict your next investment

Corporation
HEALTHCARE | Pharmaceuticals / Drugs
velomedix.com

See what CB Insights has to offer

Stage

Series B | Dead

Total Raised

$35.5M

Last Raised

$10.2M

About VeloMedix

VeloMedix is a development stage medical device company created to realize the clinical potential of mild therapeutic hypothermia in benefiting patients suffering from ischemic and reperfusion injury effects of cardiac arrest, heart attack, stroke and traumatic brain injury.

VeloMedix Headquarter Location

1455 Adams Drive Suite 1016

Menlo Park, California, 94025,

United States

650-330-7314

Latest VeloMedix News

Jeffrey Gold Appointed Chief Executive Officer of myoscience

Nov 3, 2014

November 03, 2014 16:18 ET | Source: myoscience REDWOOD CITY, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- myoscience, inc. is pleased to announce the appointment of Jeffrey Gold as Chief Executive Officer (CEO) effective immediately. Mr. Gold, who previously held the position of President & COO, is an accomplished executive, having held posts as Chief Executive for Velomedix and CryoVascular Systems as well as Chief Operating Officer for CardioThoracic Systems. "I am very pleased to handover the role of Chief Executive Officer to Jeff Gold. Jeff is a seasoned executive with a solid record of success. The myoscience Board of Directors fully supports the appointment and we are excited to have Jeff accept the leadership role as CEO," said Rich Ferrari, myoscience Executive Chairman. Prior to joining myoscience, Mr. Gold was the President & CEO of Velomedix Inc, a venture backed company that developed a unique technology for rapidly inducing therapeutic hypothermia in patients undergoing severe acute cardiovascular events, such as heart attack and cardiac arrest. Prior to Velomedix, Mr. Gold was a Venture Partner for Longitude Capital where he focused on investments in medical devices. "I am very excited to assume the responsibility of guiding myoscience through its next development stage," said Gold. "The myoscience team has built an extremely strong platform technology that targets two distinct markets, aesthetics (for facial wrinkles) and peripheral nerve pain, both with tremendous potential. The patented iovera° product platform has demonstrated the ability to improve patients' lives in the aesthetics and pain management applications that is unmatched in those fields. We have a strong team of dedicated professionals that will drive myoscience to greater success in the future. " ABOUT MYOSCIENCE Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold TherapyTM, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera° system. The iovera° system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com . The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=25085 © 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience. MKT-0327 REV A MEDIA RELATIONSPeter Osborne / Related Articles other press releases by myoscience

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing VeloMedix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

VeloMedix is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

N

Neuroscience

2,144 items

Companies developing products that monitor, analyze, protect, or otherwise influence the structure/function of the nervous system.

VeloMedix Patents

VeloMedix has filed 4 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/23/2006

3/18/2014

Medical treatments, Causes of death, Intensive care medicine, Cardiac arrhythmia, Abdomen

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/23/2006

00/00/0000

00/00/0000

00/00/0000

Grant Date

3/18/2014

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Medical treatments, Causes of death, Intensive care medicine, Cardiac arrhythmia, Abdomen

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.